Exantas Capital (NYSE:XAN) had its price target increased by stock analysts at JMP Securities from $12.00 to $12.50 in a research note issued on Thursday. The firm presently has a “market outperform” rating on the stock. JMP Securities’ price objective indicates a potential upside of 5.57% from the company’s current price.

Several other brokerages have also recently commented on XAN. Raymond James assumed coverage on shares of Exantas Capital in a report on Monday, July 30th. They issued an “outperform” rating and a $12.00 target price for the company. ValuEngine upgraded shares of Exantas Capital from a “hold” rating to a “buy” rating in a report on Friday, July 6th.

Shares of Exantas Capital opened at $11.84 on Thursday, according to MarketBeat. Exantas Capital has a one year low of $8.51 and a one year high of $11.91. The stock has a market capitalization of $366.51 million, a price-to-earnings ratio of -13.77 and a beta of 0.93. The company has a quick ratio of 130.99, a current ratio of 130.99 and a debt-to-equity ratio of 2.22.

Exantas Capital (NYSE:XAN) last announced its earnings results on Wednesday, August 1st. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.13 by $0.07. Exantas Capital had a net margin of 54.24% and a negative return on equity of 2.79%. The company had revenue of $13.65 million during the quarter, compared to analysts’ expectations of $10.40 million. analysts anticipate that Exantas Capital will post 0.44 earnings per share for the current fiscal year.

In other Exantas Capital news, Director Stephanie H. Wiggins sold 3,000 shares of the firm’s stock in a transaction dated Thursday, June 7th. The shares were sold at an average price of $9.96, for a total value of $29,880.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 4.82% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Exantas Capital in the second quarter worth approximately $29,205,000. Forward Management LLC purchased a new stake in shares of Exantas Capital in the second quarter worth approximately $9,445,000. Citadel Advisors LLC purchased a new stake in shares of Exantas Capital in the second quarter worth approximately $2,972,000. Fuller & Thaler Asset Management Inc. purchased a new stake in shares of Exantas Capital in the second quarter worth approximately $2,498,000. Finally, Acadian Asset Management LLC purchased a new stake in shares of Exantas Capital in the second quarter worth approximately $1,754,000. 51.74% of the stock is owned by institutional investors and hedge funds.

About Exantas Capital

Exantas Capital Corp. engages in the provision of real estate finance services. It focuses on originating, holding and managing commercial mortgage loans, and commercial real estate-related debt investments. The company was founded in 2005 and is headquartered in New York, NY.

Further Reading: Book Value Per Share – BVPS

Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.